Cassava Sciences Inc (SAVA)

[runncoach]

You're missing my point. That data is on CONTROLLED trials and states it in the slide. There isn't 20,000 patient studies on open label trials for mild AD so that slide is a waste for Open label comparison but gives a good idea what investors can compare to in 2+ years. I gave you a link to actual trials that show folks already on AD drugs for mild AD that show 23% are expected to improve over a year. This drug isn't being compared to NO treatment. It's compared to current SOC which is what my link showed. Everything up until this point has been open label and is impressive to me but not what some try to portray it as. If I KNOW i'm getting the drug and folks are pumping youtube videos of anecdotal reports, then me and my whole family are much more likely to claim a better response.

None of this has anything to do with the current share price. I'm just talking about the science.